Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

NEOLEUKIN THERAPEUTICS, INC.

(NLTX)
  Rapport
Vertraagde tijd Nasdaq  -  21:53:06 26-01-2023
0.6200 USD   +1.67%
03/01Neoleukin Therapeutics, Inc. : Guggenheim is minder optimistisch
MM
2022Neoleukin Therapeutics, Inc. : Mizuho Securities gaat van Kopen naar Neutraal
MM
2022Neoleukin Therapeutics, Inc. : Canaccord Genuity gaat van Kopen naar Neutraal
MM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
ETF's gepositioneerd op NEOLEUKIN THERAPEUTICS, INC.ETF's en trackers met Trackinsight
ETF gewichtVariatie 5 dagenRatingGeografie
IShares Micro-Cap ETF - USD0.01%0.02%VS
Invesco Nasdaq Biotechnology ETF - USD0%-0.05%-VS



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (ďInformationĒ) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Grafiek NEOLEUKIN THERAPEUTICS, INC.
Duur : Periode :
Neoleukin Therapeutics, Inc. : Grafische technische analyse Neoleukin Therapeutics, Inc. | MarketScreener
Grafiek op volledig scherm
Evolutie van de resultatenrekening
Consensus
Verkoop
Koop
Gemiddeld advies Houden
Aantal analisten 5
Laatste slotkoers 0,61 $
Gemiddelde koersdoel 1,30 $
Spread / Gemiddelde doel 113%
Grafiek NEOLEUKIN THERAPEUTICS, INC.
Duur : Periode :
Neoleukin Therapeutics, Inc. : Grafische technische analyse Neoleukin Therapeutics, Inc. | MarketScreener
Grafiek op volledig scherm
Sector en concurrentie
Verschil t.o.v. 1 jan (%)Kapitalisatie (M$)
NEOLEUKIN THERAPEUTICS, INC.19.80%26
MODERNA, INC.9.54%74 174
LONZA GROUP AG15.21%42 087
IQVIA HOLDINGS INC.10.55%42 070
ALNYLAM PHARMACEUTICALS, INC.-4.01%28 176
SEAGEN INC.7.39%25 624